Viewing Study NCT00003132


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-01-01 @ 6:48 AM
Study NCT ID: NCT00003132
Status: COMPLETED
Last Update Posted: 2012-11-09
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer
Sponsor: NYU Langone Health
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CDR0000065897
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View